Titian Software Ltd., a London, UK-based company that develops sample-management software and related services for life-sciences laboratories, received a majority investment from Battery Ventures.
The specific terms of the deal were not disclosed.
The company intends to use the funds for organic growth as well as potential future acquisitions.
Founded in 1999 by Edmund Wilson, who retains a meaningful ownership stake in the company and will remain closely involved in leading the business going forward, Titian makes technology for the entire sample-management process, helping customers maximize the efficiency of their research and development. More specifically, the company’s Mosaic product improves the supply of samples—including compounds, biologicals and reagents—essential to vital research and development processes in the lab. Titian sells into industries including pharmaceuticals and biopharmaceuticals; agro science; contract research organizations; and not-for-profit and academic groups.